Max representation.
Minimum time.
Balancing diversity targets and trial timelines for a hypertension drug.
Partnering for participation
An advocacy group’s relationships and respect drive minority trial recruitment.
Of the community, for the community
Trusted local voices were the key to addressing CVD in underrepresented populations.
Redefining exclusivity
Finding a new way to differentiate an existing drug in a crowded oncology market.